Exhibitors

MY Malaysia
Stand No: 14.1F30
Y.S.P. Industries (M) Sdn Bhd,a wholly owned subsidiary of Y.S.P.SAH established since 1987 with a PIC/s GMP manufacturing plant in Bangi, Malaysia. The company is involving principally the manufacturing, marketing and distribution of a wide range of generic products that include Tablet, Capsule, Eye-drops, Small Volume Injection, Syrup/Suspension, Cream/Ointment and Suppository. Our products range from a broad array of Pharmaceutical, Over the Counter (OTC), Traditional Complimentary Medicine (TCM), Cosmeceutical to Animal Health products. As corporate headquarter located in Malaysia, Y.S.P.SAH has aggressively involved in export business through our affiliates abroad, from Asia to Middle East and Africa region.
Location:
Categories:
JP Japan
Stand No: 5A4
Yamasa Biochemicals Division has advanced research for the next generation in nucleic acid related compounds which are now used in broad fields such as APIs, and pharmaceutical intermediates. Along with our abundant experience and technology accumulated for many years, Yamasa provides products and contract services which realize your various needs.
Location:
Sub-event: CPWW18
Zone: API
Yancheng Ming Yuan Pharmaceutical Co Ltd is a sales trading enterprise engaged in the veterinary pharmacation raw materials, the domestic veterinary drugs bulk drugs GPS certification through the enterprise. Strong partnership with the major pharmaceutical, veterinary raw materials producers, agents, operating varieties covering therapeutic class, more than 400 varieties of prevention class, insecticide classes, nutrition and feed additives such as major categories of raw materials (specifications).
Location:
Sub-event: CPWW18
Yangtze River Pharmaceutical Group (hereinafter refers to YRPG) is a large-scale cross-region pharmaceutical group which is one of the key enterprises in China. Founded in 1971, YRPG has been in Top 3 for comprehensive economic benefit in national pharmaceutical industry for over ten years since 1997. In 2010, the total sales revenue reached RMB 25 billion. At present, YRPG has over 8000 employees, with total assets of over RMB 9 billion and a total floor area of over 2 million square meters. With Yangtze River Pharmaceutical Co Ltd as the core entity, the group owns 7 subsidiaries in Beijing, Shanghai, Nanjing, Guangzhou etc. and has established R&D and production bases of innovative chemical medicine, patent traditional Chinese medicine (TCM) and biological medicine. YRPG is able to support a product line with diversities and sound development, and has established a product structure of 10 series, covering over 10 dosage forms and...
Location:
Sub-event: FDF18
Yangzhou Liberty Pharmaceutical Co Ltd is an API manufacturer, and a joint venture whose main body is Yangzhou Pharmaceutical Co Ltd, located in Yangzhou. In 2013, our company became the holding company of Datong Tongxing Antibiotic Co Ltd in Shanxi Province. We will also develop and produce other fermentation raw materials. With advanced quality management system, we have some products which passed the US FDA inspection and also gained COS, EU-GMP and GMP certificates.,Yangzhou Liberty Pharmaceutical Co Ltd, Anhui Liberty Pharmaceutical Co Ltd and Datong Tongxing Antibiotic Co Ltd, as your reliable partners, are determined to provide excellent products and service to friends from all over the world.
Location:
Sub-event: CPWW18
Zone: API
HK Hong Kong S.A.R., China
Stand No: 8H2
Yangzhou Pharmaceutical Co Ltd, originally Yangzhou Pharmaceutical Factory, was founded in 1958, and mainly manufactures steroid hormones, antibiotics, antihistamines, and cardiovascular products. It provides APIs and intermediates. As of June 7, 2013, Yangzhou Pharmaceutical Co., Ltd. operates as a subsidiary of Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Location:
Sub-event: CPWW18
Zone: API
Yangzhou Tianhe Pharmaceutical Co Ltd is a professional pharmaceutical APIs & intermediates manufacturer, has been committed to the development, production and marketing of innovative and cost-effective APIs like Triclabendazole, Fipronil, Fluazuron, Dicyclanil, Deltamethrin & Sulfadimethoxine, etc... We are now setting up a new facility with the area of 100,000 square meters, more innovative projects would be put into production in the near future.
Location:
Yantai Dongcheng Biochemicals, is one of the largest biochemical API manufacturers in China. The company's products have been exported to more than fifty countries. Main products including Heparin Sodium, Chondroitin sulphate, Cytochrome C, Hyaluronic Acid, Collagen, and Glucosamine etc are in compliance with the EP, JP and USP. For Heparin Sodium, we have passed U.S. FDA site audit, German Hamburg GMP certificate, European CEP certificate. For Chondroitin sulphate, we have achieved FDA DMF registration number and European CEP certificate. Furthermore, YanTai DongCheng has passed SFDA GMP audit, and achieved DNV ISO9001 International Quality System certification.
Location:
Sub-event: CPWW18
Zone: API
TR Turkey
Stand No: 14.1J83
Our company, founded in 1975 by Pharmacist Arif Tama&ccedil, is operating all around Turkey with 80 employees. Our company is specialized on diagnosis oriented gastroenterological and radiological medicines and devices, being market leader for Barium Sulfate, laxatives/purgatives and enemas. We also sell three nose decongestant sprays and medical devices used for diagnostic in gastroenterology and radiology.
Location:
We are a professional manufacturer and supplier of pharmaceutical machinery. Our main products include wet granulator, fluid bed dryer, bin blender, coating machine, lifter and washing station. We provide first-class GMP, CGMP, FDA, CE, TUV, ISO9001:2008 standard machinery and total pharmaceutical solution & complete set of equipment. All products are widely used in Pharmaceutical, Chemical, Foodstuff industry.
Location:
Sub-event: ICSE18
Zone: LabWorld
CN China
Stand No: 10B4NEP
Location:
Sub-event: CPWW18
Zone: API
CN China
Stand No: 14.0B82
Shijiazhuang Yiling Pharmaceutical Co Ltd engages in the research and development, production, and sale of medicines primarily in China. It offers drugs, chemical medicines, and health products. The company offers its products primarily for cardiovascular, cerebrovascular, cold respiratory, and other diseases. Shijiazhuang Yiling Pharmaceutical Co., Ltd. is based in Shijiazhuang, China.
Location:
Yingkou Sanzheng New Technology Chemical Industry Co Ltd specializes in pharmaceutical intermediates, fine chemicals & custom synthesis. The company has rich resource of CNCl, HCN and H2 and has been developing products based on these raw materials. We are also your right partner for custom production. Our leading products are:- Chlorosulfonyl Isocyanate, Sodium Dicyanamide, Sodium Cyanoborohydride, 1,3 -Diaminoguanidine HCl, 3-Butyu-1-0l, and 9-azabicyclo[3.3.1]nonan-3-one.Looking forward to good cooperation with you!
Location:
Sub-event: CPWW18
Zone: API
CN China
Stand No: 6A40
Yino Pharma Limited is fully integrated EU-GMP certified producer of Heparin range Anticoagulants: Heparin Sodium (EU-GMP), Heparin Calcium (EU-GMP applied), Dermatan Sulfate, Heparinoid Sodium, Mucopolysaccharide Polysulfate, Enoxaparin Sodium (EU-GMP applied). Further Heparin derivatives under development. Best possible implementation of Annex 2 to EU-GMP Guidelines and FDA Guidance for Industry: From intestine to API - all at one site. Additional facility for biological active substances: Bile Derivatives, Black Currant Extract, Chondroitin Sulfate Sodium, Chondroitin Sulfate Calcium, Liver Extract, Pancreatin (EU-GMP applied), Lung Surfactant.
Location:
Sub-event: CPWW18
Zone: API
CN China
Stand No: 10C42
New
Location:
Sub-event: CPWW18
Zone: API
DE Germany
Stand No: 4G2
YMC Europe offers a wide range of (U)HPLC and HPLC columns, silica for preparative chromatography, glass- and Pilot-columns as well as service for application and method development on demand. As a new field of business YMC is strongly approaching the sector of micro reaction technology and continuous synthesis. This new sector of products, developed and engineered in YMC facilities, will also be available worldwide supported by dedicated YMC product specialists. An extensive distribution network guarantees availability of the products in countries all over the world.
Location:
Sub-event: ICSE18
Zone: PMEC
KR South Korea
Stand No: 9B32
YONSUNG's highest priority is the top quality of APIs. We manufacture APIs in accordance with ICH Guidelines (Q7) and export to the US, EU, Japan and other countries. YONSUNG continuously monitors new requirements from the FDA, ICH, EMEA and WHO. YONSUNG is fully approved by USFDA, European and Japanese authorities for the development and manufacture of APIs.
Location:
Categories:
CH Switzerland
Stand No: 2F21
The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years' experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of injections pens, autoinjectors and infusion systems to administer liquid drugs. Ypsomed promotes and sells its product portfolio under the umbrella brands, mylife Diabetescare directly to patients or through pharmacies and clinics, and under YDS Ypsomed Delivery Systems as business-to-business to pharmaceutical companies. Ypsomed has its headquarters in Burgdorf, Switzerland, and operates a global network of manufacturing sites, subsidiaries and distributors. The Ypsomed Group employs around 1350 employees.
Location:
Sub-event: IP2018
Zone: InnoPack
Yueyang Xiangmao Medicines & Chemicals Co., Ltd. is the enterprise which dedicates to specialization production of Methyl Sulfonyl Methane and faces global market. At present, we can produce methyl sulfone with many specifications and many applications. Product specification include 5-20 mesh, 20~40mesh, 40~60mesh, 60-80mesh, 80-100 mesh and others. We can still produce methyl sulfone with special specification.
Location:
JP Japan
Stand No: 5A80
Since its foundation more than 70 years ago, Yuki Gosei Kogyo Co., Ltd. has used its unique and proprietary technologies to research, develop, and manufacture a variety of fine chemical products beneficial for human life and health. We will continue to expand our existing lines while developing new business frontiers based on fine chemicals where Yuki Gosei's long expertise can be best applied. The development of active pharmaceutical ingredients and high value intermediates is our highest priority. We are also focusing on the new applications for our existing products such as Glycine, pyridine and piperidine compounds as well as silicon-based compounds,
Location:
Sub-event: CPWW18
Zone: API
TW Taiwan
Stand No: 14.0B12
YungShin started its business in 1952 and since 1978 YungShin has also established affiliates worldwide including Yung Zip Chemical in Taiwan, CTI in the US, YSP Southeast Asia and YSP China. YungShin specializes in the development and production for finished products and APIs. YungShin is also strict in adherence to the most sophisticated ERP system, SAP, SOPs and diligent compliance to PIC/S GMP, Japanese MHLW and US FDA regulations. YungShin provides integrated drug development and contract manufacturing services from Taiwan facilities.
Location:
CN China
Stand No: 4J35NEP
New
Location:
Sub-event: CPWW18
Zone: API
UA Ukraine
Stand No: 14.0J32
YURiA-PHARM is the leading manufacturer of solutions for infusion in Ukraine and former CIS countries. We supply medical facilities with more than 100 items of blood- and plasma substitute solutions, original infusion drugs, antibiotics, fungicidal drugs, syrups, antiseptics, parenteral nourishment preparations, parenteral anti-tuberculosis drugs, syringes, I.V. sets. Our product line sums up to more than 10 0 infusions , completely covering the needs of medical facilities in infusion therapy. At the moment our products are released in 9 forms , including prefilled syringes, nebules, bags for irrigation solutions, polypropylene bags, PVC bags, glass bottles, plastic bottles. In 2011 «YURiA-PHARM» has complited GMP certification (Ukraine, EU, Kenya). The newest product we are offering is Xelagel - a substance (API) of srosslinked/stabilized hyaluronic acid.
Location:
Categories: